Spots Global Cancer Trial Database for tasquinimod
Every month we try and update this database with for tasquinimod cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer | NCT01513733 | Prostate Cancer | tasquinimod tasquinimod 0.2... tasquinimod 0.2... | 18 Years - 79 Years | Duke University | |
| Tasquinimod for the Treatment of Relapsed or Refractory Myeloma | NCT04405167 | Multiple Myelom... | Tasquinimod IRd chemotherap... | 18 Years - | University of Pennsylvania | |
| The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer | NCT01513733 | Prostate Cancer | tasquinimod tasquinimod 0.2... tasquinimod 0.2... | 18 Years - 79 Years | Duke University | |
| Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02159950 | Hormone-Resista... Metastatic Pros... Recurrent Prost... Stage IV Prosta... | Laboratory Biom... Sipuleucel-T Tasquinimod | 18 Years - | Roswell Park Cancer Institute | |
| Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02159950 | Hormone-Resista... Metastatic Pros... Recurrent Prost... Stage IV Prosta... | Laboratory Biom... Sipuleucel-T Tasquinimod | 18 Years - | Roswell Park Cancer Institute | |
| A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy | NCT01732549 | Metastatic Cast... | Tasquinimod Placebo | 18 Years - | Ipsen | |
| A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy | NCT01732549 | Metastatic Cast... | Tasquinimod Placebo | 18 Years - | Ipsen | |
| Tasquinimod for the Treatment of Relapsed or Refractory Myeloma | NCT04405167 | Multiple Myelom... | Tasquinimod IRd chemotherap... | 18 Years - | University of Pennsylvania | |
| A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer | NCT02396368 | Prostate Cancer Bone-only Metas... | Tasquinimod Radium 223 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | NCT01234311 | Prostate Cancer | tasquinimod Placebo | 18 Years - | Active Biotech AB | |
| Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer | NCT02057666 | Prostatic Neopl... | Tasquinimod Placebo | 20 Years - | Ipsen | |
| Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) | NCT06327100 | Primary Myelofi... Post-polycythem... Post-Essential ... | Ruxolitinib Tasquinimod | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
